Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Hande

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Cancer|April 1, 1986
Treatment of intraocular lymphoma with high-dose Ara-CM A Baumann, P S Ritch, K R Hande, et al.
Cancer|January 15, 1992
A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancerP B Murphy, J D Hainsworth, F A Greco, et al.
Annals of Internal Medicine|July 1, 1986
Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testisD C Doll, A F List, F A Greco, et al.
Seminars in Oncology|March 1, 1985
High-dose etoposide (VP-16) in small-cell lung cancerF A Greco, D H Johnson, K R Hande, et al.
Cancer Treatment Reports|November 1, 1981
Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancerJ A Knost, F A Greco, K R Hande, et al.
Seminars in Oncology|February 1, 1992
Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trialD H Johnson, R DeVore, F A Greco, et al.
Seminars in Oncology|September 1, 1986
High-dose pilot studies in extensive-stage small-cell lung cancerD H Johnson, K R Hande, L L Porter, et al.
Cancer Research|January 1, 1984
Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patientsK R Hande, P J Wedlund, R M Noone, et al.
Clinical Breast Cancer|March 20, 2002
Paclitaxel, 5-fluorouracil, and leucovorin (TFL) in the treatment of metastatic breast cancerB P Nicholson, D M Paul, K R Hande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancerD H Johnson, M J DeLeo, K R Hande, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Cancer|April 1, 1986
Treatment of intraocular lymphoma with high-dose Ara-CM A Baumann, P S Ritch, K R Hande, et al.
Cancer|January 15, 1992
A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancerP B Murphy, J D Hainsworth, F A Greco, et al.
Annals of Internal Medicine|July 1, 1986
Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testisD C Doll, A F List, F A Greco, et al.
Seminars in Oncology|March 1, 1985
High-dose etoposide (VP-16) in small-cell lung cancerF A Greco, D H Johnson, K R Hande, et al.
Cancer Treatment Reports|November 1, 1981
Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancerJ A Knost, F A Greco, K R Hande, et al.
Seminars in Oncology|February 1, 1992
Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trialD H Johnson, R DeVore, F A Greco, et al.
Seminars in Oncology|September 1, 1986
High-dose pilot studies in extensive-stage small-cell lung cancerD H Johnson, K R Hande, L L Porter, et al.
Cancer Research|January 1, 1984
Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patientsK R Hande, P J Wedlund, R M Noone, et al.
Clinical Breast Cancer|March 20, 2002
Paclitaxel, 5-fluorouracil, and leucovorin (TFL) in the treatment of metastatic breast cancerB P Nicholson, D M Paul, K R Hande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancerD H Johnson, M J DeLeo, K R Hande, et al.
Pageof 11